Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

GlaxoSmithKline plc (GSK)

43.08   0.32 (0.75%) 02-21 16:02
Open: 42.82 Pre. Close: 42.76
High: 43.2 Low: 42.76
Volume: 3,832,924 Market Cap: 107787M
GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 43.301 - 43.587 43.587 - 43.847
Low: 42.039 - 42.411 42.411 - 42.747
Close: 42.511 - 43.091 43.091 - 43.615

Technical analysis

as of: 2020-02-21 4:30:37 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 53.79     One year: 56.36
Support: Support1: 42.51    Support2: 35.37
Resistance: Resistance1: 46.06    Resistance2: 48.25
Pivot: 44.50
Moving Average: MA(5): 43.32     MA(20): 45.11
MA(100): 44.99     MA(250): 42.38
MACD: MACD(12,26): -0.94     Signal(9): -0.71
Stochastic oscillator: %K(14,3): 7.12     %D(3): 6.07
RSI: RSI(14): 30.31
52-week: High: 48.25  Low: 38.43  Change(%): 6.4
Average Vol(K): 3-Month: 308735  10-Days: 373804

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
GSK has closed above bottom band by 23.1%. Bollinger Bands are 106.5% wider than normal. The large width of the bands suggest high volatility as compared to GSK's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Sun, 23 Feb 2020 12:07:00 +0000
Better Buy: GlaxoSmithKline vs. Eli Lilly

Fri, 21 Feb 2020 21:42:00 +0000
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality

Fri, 21 Feb 2020 18:55:00 +0000
A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward

Fri, 21 Feb 2020 02:25:00 +0000
Merck's Chief Digital Officer Leaves to Join Marriott

Fri, 21 Feb 2020 02:25:00 +0000
Merck's Chief Digital Officer Leaves to Join Marriott

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2510.00
Shares Float (M) 2450.00
% Held by Insiders 0.01
% Held by Institutions 11.85
Shares Short (K) 7270
Shares Short P. Month (K)

Stock Financials

EPS 0.990
Book Value (p.s.) 2.410
PEG Ratio 4.14
Profit Margin 13.76
Operating Margin
Return on Assets (ttm) 7.4
Return on Equity (ttm) 47.8
Qtrly Rev. Growth 8.6
Gross Profit (p.s.) 9.147
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 6.90
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E 43.52
P/E Growth Ratio 0.01
P/BV 17.88

Dividends & Splits

Dividend 1.060
Dividend Yield 0.02
Dividend Pay Date 2020-04-08
Ex-Dividend Date 2020-02-19
Forward Dividend 2.400
Last Split Date
Last Split Ratio 2
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.